Stock Analysis of Smith & Nephew SNATS Inc (SNN) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code SNN
Close 25.33
Change 0.310 / 1.24 %
Volume 504539
Vol Change -262891.00 / 34.26 %
IndustryMedical Devices
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Poor Growth Stock
Value Index Very Low Value Stock
Profitability Index Very Low Profitability Stock
Stability Index Mild Stability


Fundamental View of Smith & Nephew SNATS Inc


Highs/Lows of Smith & Nephew SNATS Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week24.87 1.85 % 0.513 % 25.3324.7531-May-2429-May-24
Two Week26.09 2.91 % 0.486 % 26.1224.620-May-2423-May-24
One Month24.13 4.97 % 4.80 % 26.1324.1317-May-2401-May-24
Three Month26.51 4.45 % 3.56 % 28.1523.6512-Mar-2416-Apr-24
Six Months25.95 2.39 % 15.54 % 28.9323.6522-Feb-2416-Apr-24
One year29.9 15.28 % 26.26 % 32.28521.52530-Jun-2327-Oct-23
Two year32.73 22.61 % 27.72 % 33.08521.52528-Apr-2327-Oct-23
Five year42.27 40.08 % 91.77 % 33.08521.52528-Apr-2327-Oct-23
Ten year35.108 27.85 % 174.36 % 52.2621.52520-Feb-2027-Oct-23


Technical View of Smith & Nephew SNATS Inc






Charts of Smith & Nephew SNATS Inc


Returns of Smith & Nephew SNATS Inc with Peers
Period / StockSNNSWAVPODDBRKRRDY
1 Week1.85%0.195%-1.60%-15.20%-1.22%
1 Mth4.97%1.38%3.05%-16.02%-6.52%
3 Mth-4.45%28.32%8.04%-24.30%-10.55%
6mth-2.39%91.78%-6.29%0.645%-1.75%
1 Year-15.28%21.22%-35.39%-5.20%24.44%
2 Year-22.61%92.02%-17.00%4.85%24.08%
5 Years-40.08%446.00%61.39%56.84%80.22%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Smith & Nephew SNATS Inc with Peers
Ratio / StockSNNSWAVPODDBRKRRDY
PE56.1278.3441.3123.930.205
P/B4.1819.9615.167.350.0435
ROA3.9513.079.479.9415.77
ROE7.5725.4736.7030.9621.73
Debt To Equity0.5641.101.930.9470.050
Revenue5549.00 M
6.40 %
730230 K
49.11 %
1557.00 M
19.28 %
2964.50 M
17.14 %
279164 M
13.54 %
Net Income263000 K
17.94 %
147278 K
31.81 %
120000 K
2508.70 %
427200 K
44.03 %
55684.00 M
23.54 %


Technicals of Smith & Nephew SNATS Inc with Peers
Technical / StockSNNSWAVPODDBRKRRDY-
ADX18.2853.9628.0736.8924.70
CMF-0.142-0.395-0.084-0.097-0.198
MFI64.6147.6662.9925.7549.66
RSI53.0377.6251.3228.2438.95
MACD Abv SignalFalseFalseFalseFalseTrue
Price Above 50 MATrueTrueTrueFalseFalse-
Price Above 200 MAFalseTrueFalseFalseFalse-


About : Smith & Nephew SNATS Inc


Address : Building 5, Watford, United Kingdom, WD18 8YE
Tel : 44 1923 477 100
URL : https://www.smith-nephew.com
Code : SNN, ISIN : US83175M2052, Exchange : NYSE, Country : USA
Fiscal Year End : December
IPO date : 16_Nov_1999
Employee Count : 18452

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.


Note : All Data Generated at the End of Trading Hours (EOD Data)